Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26F0WU5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,935
Award facts
- Contract value 100% obligated
- $22,934.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,934.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector units. The order, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a competitive award with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply diverse pharmaceutical products, including specialty medications, biologics, vaccines, and medical devices across multiple therapeutic domains. Enbrel, a TNF inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, represents a specialized pharmaceutical product consistent with the company's role as a prime pharmaceutical vendor supporting the Defense Health Agency and other government healthcare systems. The rapid completion timeframe reflects the delivery order execution typical of established IDC arrangements.
Quick answers
Who was awarded contract SPE2DR26F0WU5?
SPE2DR26F0WU5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F0WU5 worth?
The government has obligated $22,935 on SPE2DR26F0WU5.
Is contract SPE2DR26F0WU5 an order under another contract?
Yes. SPE2DR26F0WU5 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0WU5 competed?
The extent of competition for SPE2DR26F0WU5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award